Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor

Org Lett. 2016 Dec 16;18(24):6496-6499. doi: 10.1021/acs.orglett.6b03435. Epub 2016 Dec 7.

Abstract

Autoimmune and inflammatory diseases are associated with inappropriate activation of the NOD-like receptor protein 3 (NLRP3) inflammasome, but suitable inhibitors against such improper activations remain scarce. Here, spirodalesol (1) from Daldinia eschscholzii was structurally characterized and is biosynthetically proposed as an NLRP3 inflammasome activation inhibitor with an unprecedented carbon skeleton.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Inflammasomes / antagonists & inhibitors*
  • Inflammasomes / metabolism
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Mice
  • Models, Molecular
  • Molecular Structure
  • NLR Family, Pyrin Domain-Containing 3 Protein / antagonists & inhibitors*
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Polyketides / chemistry
  • Polyketides / metabolism
  • Polyketides / pharmacology*
  • Structure-Activity Relationship
  • Xylariales / chemistry*

Substances

  • Inflammasomes
  • Lipopolysaccharides
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Polyketides
  • spirodalesol